Amgen Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 6,594 million compared to USD 6,526 million a year ago. Net income was USD 1,317 million compared to USD 464 million a year ago. Basic earnings per share from continuing operations was USD 2.46 compared to USD 0.81 a year ago. Diluted earnings per share from continuing operations was USD 2.45 compared to USD 0.81 a year ago.
For the six months, revenue was USD 12,832 million compared to USD 12,427 million a year ago. Net income was USD 2,793 million compared to USD 2,110 million a year ago. Basic earnings per share from continuing operations was USD 5.16 compared to USD 3.67 a year ago. Diluted earnings per share from continuing operations was USD 5.13 compared to USD 3.65 a year ago.